ERYC SPRINKLES Drug Patent Profile
✉ Email this page to a colleague
When do Eryc Sprinkles patents expire, and what generic alternatives are available?
Eryc Sprinkles is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in ERYC SPRINKLES is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eryc Sprinkles
A generic version of ERYC SPRINKLES was approved as erythromycin by TORRENT on July 6th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERYC SPRINKLES?
- What are the global sales for ERYC SPRINKLES?
- What is Average Wholesale Price for ERYC SPRINKLES?
Summary for ERYC SPRINKLES
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Clinical Trials: | 10 |
| Patent Applications: | 5,151 |
| DailyMed Link: | ERYC SPRINKLES at DailyMed |
Recent Clinical Trials for ERYC SPRINKLES
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University Medical Center | Phase 2 |
| St. Jude Children's Research Hospital | Phase 2 |
| EMAS Pharma | Phase 1 |
US Patents and Regulatory Information for ERYC SPRINKLES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | ERYC SPRINKLES | erythromycin | CAPSULE, DELAYED REL PELLETS;ORAL | 050593-001 | Jul 22, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
